We are live on ! Find out more
NTC

North Tide Capital Portfolio holdings

AUM $469M
1-Year Est. Return 6.57%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$469M
AUM Growth
+$19.5M
Cap. Flow
+$13.3M
Cap. Flow %
2.84%
Top 10 Hldgs %
91.11%
Holding
16
New
4
Increased
5
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$54.6M
2
ESRX
Express Scripts Holding Company
ESRX
+$21.8M
3
CVS icon
CVS Health
CVS
+$19.8M
4
IVC
Invacare Corporation
IVC
+$14.6M
5
SVU
SUPERVALU Inc.
SVU
+$12.7M

Top Sells

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$67.8M
2
GILD icon
Gilead Sciences
GILD
+$38.2M
3
IPXL
Impax Laboratories, Inc.
IPXL
+$16.1M
4
SEM
Select Medical
SEM
+$8.57M
5
OPCH icon
Option Care Health
OPCH
+$8.14M

Sector Composition

Rank Sector Weight
1 Healthcare 87.29%

No holdings matched the selected filter criteria.

Similar funds

SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return
DG
Davidson & Garrard Lynchburg, Virginia $425M AUM 14.62% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
JWM
Jacobus Wealth Management Milwaukee, Wisconsin $382M AUM 16.31% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
MCL
MIK Capital LLC New York $344M AUM 26.72% 1-Year Est. Return
GIIO
Gen IV Investment Opportunities New York $269M AUM 21.06% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

North Tide Capital's Q3 2017 Portfolio in Review

As of Q3 2017, North Tide Capital held 16 positions worth $469M, up 4.3% from $449M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

North Tide Capital's Q3 2017 filing shows 4 new, 5 increased, 3 reduced and 3 closed positions. Its largest new stake was Express Scripts Holding Company: 350,000 shares worth $22.2M. The largest sale was Tivity Health, Inc. Common Stock, an estimated $67.8M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 89% a quarter earlier.

  • North Tide Capital's largest Q3 2017 buy was Express Scripts Holding Company: 350,000 shares worth $22.2M.
  • North Tide Capital added most to McKesson in Q3 2017, an estimated $54.6M increase.
  • North Tide Capital's biggest Q3 2017 reduction was Tivity Health, Inc. Common Stock, cutting an estimated $67.8M.
  • North Tide Capital fully exited Impax Laboratories, Inc. in Q3 2017, selling an estimated $16.1M.
  • North Tide Capital's ten largest holdings make up 91% of its $469M portfolio in Q3 2017.
  • North Tide Capital opened 4 new positions and closed 3 in Q3 2017.
  • North Tide Capital's portfolio value rose 4.3% quarter-over-quarter to $469M.

Based on North Tide Capital's 13F filing for Q3 2017, filed 14 Nov 2017.